Follow on Google News News By Tag * Gen * Genetic Engineering Biotechnology News * Lasker Awards * Stem Cells * Cancer Research * Biotech * Mary Ann Liebert Inc * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | 2009 Lasker Awards Recognize Promise of Stem Cells—Global Market Could Top $700 MillionThe recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine.
2009 Lasker Awards Recognize Promise of Stem Cells—Global Market Could Top $700 Million Predicts Genetic Engineering & Biotechnology News (GEN) GROUNDBREAKING WORK IN CANCER AND STEM CELL RESEARCH HIGHLIGHTS TREMENDOUS MEDICAL AND FINANCIAL POTENTIAL OF EMERGING BIOTECHNOLOGIES New Rochelle, NY—The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, http://www.genengnews.com) The Albert Lasker Basic Medical Research Award for 2009 recognizes discoveries in the process that instructs specialized adult cells to form stem cells, and will be presented to Sir John Gurdon, DPhil, DSc, FRS, Emeritus Professor and Group Leader, Gurdon Institute of Cancer & Developmental Biology, University of Cambridge, and Shinya Yamanaka, MD, PhD, Institute for Integrated Cell-Material Sciences, Kyoto University. The 2009 Lasker-DeBakey Clinical Medical Research Award honors outstanding therapeutic research on chronic myeloid leukemia, and will be given to Brian J. Druker, MD, Professor of Medicine and Director of the Leukemia Center, Oregon Health Sciences University, Nicholas B. Lydon, PhD, formerly of Novartis, and Charles L. Sawyers, MD, Head of the Laboratory in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center. Providing insight and expert commentary on the awards in an article appearing today on the GEN website (http://www.genengnews.com) are prominent scientists Professor Sir Ian Wilmut, editor of the journal Cloning and Stem Cells (www.liebertpub.com/ “The 2009 Lasker Awards for basic and clinical research underscore the enormous impact that scientific research and translational medicine will have on human health,” said John Sterling, Editor in Chief of GEN. “In the areas of embryonic and adult stem cells, this international recognition of the implications for nuclear reprogramming techniques and the ability to produce stem cells capable of regenerating tissues and organs damaged by disease, trauma, or age, will ignite new research ventures and collaborative partnerships and spark investment across the life sciences sector.” “Both embryonic and adult stem cells offer enormous promise for new treatments and cures,” said Mary Ann Liebert, president and CEO of Mary Ann Liebert, Inc. “It is urgent that any health care reform policy ensures coverage for stem cell therapies, gene therapies, tissue engineering, and other regenerative therapeutics and technologies,” Genetic Engineering & Biotechnology News (GEN), the industry-leading biotechnology trade magazine published 21 times a year by Mary Ann Liebert, Inc., was the first in its field and is today the industry’s most widely read publication worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnosis. Mary Ann Liebert, Inc. (http://www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 www.liebertpub.com Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101 Genetic Engineering & Biotechnology News (GEN) 140 Huguenot St., New Rochelle, NY 10801-5215 www.genengnews.com Phone: (914) 740-2100 (800) 799-9GEN Fax: (914) 740-2201 # # # Genetic Engineering & Biotechnology News (GEN), the industry-leading biotechnology trade magazine published 21 times a year by Mary Ann Liebert, Inc., was the first in its field and is today the industry’s most widely read publication worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnosis. Mary Ann Liebert, Inc. (www.liebertpub.com) End
Account Email Address Disclaimer Report Abuse
|
|